Ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine
C45H54N16O7 — CID 159628927
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine
Ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine (PubChem CID 159628927) has the molecular formula C45H54N16O7 and a molecular weight of 931.03 g/mol. Its IUPAC name is ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine.
Molecular Properties
| Compound Name | Ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine |
|---|---|
| PubChem CID | 159628927 |
| Molecular Formula | C45H54N16O7 |
| Molecular Weight | 931.03 g/mol |
| Exact Mass | 930.44 |
| IUPAC Name | ethyl 2-[2-(1,3-benzodioxol-5-yl)ethylcarbamoyl-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methyl]amino]acetate;ethyl 2-[(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methylamino]acetate;(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine |
| SMILES | CCOC(=O)CN(Cc1cc(C)nc(-n2ccnc2)n1)C(=O)NCCc1ccc2c(c1)OCO2.CCOC(=O)CNCc1cc(C)nc(-n2ccnc2)n1.Cc1cc(CN)nc(-n2ccnc2)n1 |
| InChI | InChI=1S/C23H26N6O5.C13H17N5O2.C9H11N5/c1-3-32-21(30)13-29(12-18-10-16(2)26-22(27-18)28-9-8-24-14-28)23(31)25-7-6-17-4-5-19-20(11-17)34-15-33-19;1-3-20-12(19)8-15-7-11-6-10(2)16-13(17-11)18-5-4-14-9-18;1-7-4-8(5-10)13-9(12-7)14-3-2-11-6-14/h4-5,8-11,14H,3,6-7,12-13,15H2,1-2H3,(H,25,31);4-6,9,15H,3,7-8H2,1-2H3;2-4,6H,5,10H2,1H3 |
| InChIKey | MOWDNYBZOMHQMO-UHFFFAOYSA-N |
| XLogP | 3.07 |
| TPSA | 272.25 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 931.03 |
| LogP ≤ 5 | 3.07 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159628927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.